These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 23144046)

  • 41. Copeptin and insulin-like growth factor binding protein-1 during follow-up after an acute myocardial infarction in patients with type 2 diabetes: A report from the Diabetes Mellitus Insulin-Glucose Infusion in Acute Myocardial Infarction 2 cohort.
    Smáradóttir MI; Catrina SB; Brismar K; Norhammar A; Gyberg V; Mellbin LG
    Diab Vasc Dis Res; 2019 Jan; 16(1):22-27. PubMed ID: 30309264
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Inverse relation of body weight and weight change with mortality and morbidity in patients with type 2 diabetes and cardiovascular co-morbidity: an analysis of the PROactive study population.
    Doehner W; Erdmann E; Cairns R; Clark AL; Dormandy JA; Ferrannini E; Anker SD
    Int J Cardiol; 2012 Dec; 162(1):20-6. PubMed ID: 22037349
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Effects of insulin treatment on cause-specific one-year mortality and morbidity in diabetic patients with acute myocardial infarction. DIGAMI Study Group. Diabetes Insulin-Glucose in Acute Myocardial Infarction.
    Malmberg K; Rydén L; Hamsten A; Herlitz J; Waldenström A; Wedel H
    Eur Heart J; 1996 Sep; 17(9):1337-44. PubMed ID: 8880018
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Glycaemic variability is associated with severity of coronary artery disease in patients with poorly controlled type 2 diabetes and acute myocardial infarction.
    Benalia M; Zeller M; Mouhat B; Guenancia C; Yameogo V; Greco C; Yao H; Maza M; Vergès B; Cottin Y
    Diabetes Metab; 2019 Oct; 45(5):446-452. PubMed ID: 30763700
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Effects of intensive insulin therapy after an acute myocardial infarction in patients with type 2 diabetes: results of the DIGAMI-2 trial].
    Scheen AJ; Radermecker RP; Philips JC
    Rev Med Liege; 2004 Sep; 59(9):534-9. PubMed ID: 15559444
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Temporal trends and hospital variation in the management of severe hyperglycemia among patients with acute myocardial infarction in the United States.
    Venkitachalam L; McGuire DK; Gosch K; Lipska K; Inzucchi SE; Lind M; Goyal A; Spertus JA; Masoudi FA; Jones PG; Kosiborod M
    Am Heart J; 2013 Aug; 166(2):315-324.e1. PubMed ID: 23895815
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Prognostic implications of glucose-lowering treatment in patients with acute myocardial infarction and diabetes: experiences from an extended follow-up of the Diabetes Mellitus Insulin-Glucose Infusion in Acute Myocardial Infarction (DIGAMI) 2 Study.
    Mellbin LG; Malmberg K; Norhammar A; Wedel H; Rydén L;
    Diabetologia; 2011 Jun; 54(6):1308-17. PubMed ID: 21359582
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Feasibility of insulin-glucose infusion in diabetic patients with acute myocardial infarction. A report from the multicenter trial: DIGAMI.
    Malmberg KA; Efendic S; Rydén LE
    Diabetes Care; 1994 Sep; 17(9):1007-14. PubMed ID: 7988298
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Glycometabolic state at admission: important risk marker of mortality in conventionally treated patients with diabetes mellitus and acute myocardial infarction: long-term results from the Diabetes and Insulin-Glucose Infusion in Acute Myocardial Infarction (DIGAMI) study.
    Malmberg K; Norhammar A; Wedel H; Rydén L
    Circulation; 1999 May; 99(20):2626-32. PubMed ID: 10338454
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Antihyperglycemic therapy and cardiovascular outcomes after acute myocardial infarction in elderly patients with diabetes.
    Nijjar AP; Wang H; Quan H; Khan NA
    Can J Diabetes; 2014 Dec; 38(6):396-400. PubMed ID: 25201773
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Relationship between spontaneous and iatrogenic hypoglycemia and mortality in patients hospitalized with acute myocardial infarction.
    Kosiborod M; Inzucchi SE; Goyal A; Krumholz HM; Masoudi FA; Xiao L; Spertus JA
    JAMA; 2009 Apr; 301(15):1556-64. PubMed ID: 19366775
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Poststroke glycemic variability increased recurrent cardiovascular events in diabetic patients.
    Yoon JE; Sunwoo JS; Kim JS; Roh H; Ahn MY; Woo HY; Lee KB
    J Diabetes Complications; 2017 Feb; 31(2):390-394. PubMed ID: 27956053
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Severe hypertriglyceridaemia in Type 2 diabetes mellitus: beneficial effect of continuous insulin infusion.
    Henderson SR; Maitland R; Mustafa OG; Miell J; Crook MA; Kottegoda SR
    QJM; 2013 Apr; 106(4):355-9. PubMed ID: 23417910
    [TBL] [Abstract][Full Text] [Related]  

  • 54. One- and five-year risk of death and cardiovascular complications for hospitalized patients with hyperglycemia without diagnosed diabetes: An observational study.
    Tuna M; Manuel DG; Bennett C; Lawrence N; van Walraven C; Keely E; Malcolm J; D Reid R; Forster AJ
    J Hosp Med; 2014 Jun; 9(6):365-71. PubMed ID: 24610578
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Optimisation of glycaemic control during episodes of severe/acute hyperglycaemia in patients with type 2 diabetes mellitus.
    Huri HZ; Makmor-Bakry M; Hashim R; Mustafa N; Wan Ngah WZ
    Int J Clin Pharm; 2012 Dec; 34(6):863-70. PubMed ID: 22869200
    [TBL] [Abstract][Full Text] [Related]  

  • 56. DIGAMI (Diabetes Mellitus, Insulin Glucose Infusion in Acute Myocardial Infarction): theory and practice.
    Davies MJ; Lawrence IG
    Diabetes Obes Metab; 2002 Sep; 4(5):289-95. PubMed ID: 12190991
    [No Abstract]   [Full Text] [Related]  

  • 57. Differential clinical outcomes associated with hypoglycemia and hyperglycemia in acute myocardial infarction.
    Goyal A; Mehta SR; Díaz R; Gerstein HC; Afzal R; Xavier D; Liu L; Pais P; Yusuf S
    Circulation; 2009 Dec; 120(24):2429-37. PubMed ID: 19948980
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Effects of intensive glycaemic control on ischaemic heart disease: analysis of data from the randomised, controlled ACCORD trial.
    Gerstein HC; Miller ME; Ismail-Beigi F; Largay J; McDonald C; Lochnan HA; Booth GL;
    Lancet; 2014 Nov; 384(9958):1936-41. PubMed ID: 25088437
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Job insecurity and prognosis after myocardial infarction: the SHEEP Study.
    László KD; Engström K; Hallqvist J; Ahlbom A; Janszky I
    Int J Cardiol; 2013 Sep; 167(6):2824-30. PubMed ID: 22884696
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Hyperglycaemia is associated with worse outcomes in Latin-American individuals with acute myocardial infarction].
    Gomez-Arbelaez D; Sánchez-Vallejo G; Perez M; Garcia RG; Arguello JF; Peñaherrera E; Duarte YC; Casanova ME; Accini JL; Sotomayor A; Camacho PA; Lopez-Jaramillo P
    Clin Investig Arterioscler; 2016; 28(1):9-18. PubMed ID: 26596523
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.